Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage
Phase 2
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Gastric Cancer, Pancreatic Cancer
Both
Gastric Cancer, Pancreatic Cancer
Trial Information
Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage
Inclusion Criteria:
- Men and women 18 years of age and older
- Informed consent in keeping with the policies of Memorial Sloan-Kettering Cancer
Center
- Presentation of gastric or pancreatic cancer based on objective findings by either:
- CT scan
- Endoscopy
- Pathologic examination
- Candidate for surgical treatment and are scheduled for laparoscopy with peritoneal
lavage.
Exclusion Criteria:
- Under 18 years of age
- Inability to speak or read English, and an appropriate translator is not identifiable
- Unable or unwilling to give informed consent
- Patients with synchronous cancers of other abdominal organs
- Multiple prior surgical procedures on the abdomen where the surgeon feels that
percutaneous lavage may be dangerous.
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
To determine if the cytology results from percutaneous peritoneal lavage are in concordance with the cytology from laparoscopically guided peritoneal lavage.
Outcome Time Frame:
2 years
Safety Issue:
No
Principal Investigator
T. Peter Kingham, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Memorial Sloan-Kettering Cancer Center
Authority:
United States: Institutional Review Board
Study ID:
10-011
NCT ID:
NCT01132755
Start Date:
May 2010
Completion Date:
May 2013
Related Keywords:
- Gastric Cancer
- Pancreatic Cancer
- gastric
- pancreas
- laparoscopy
- peritoneal lavage
- 10-011
- gastric and pancreatic cancer
- Stomach Neoplasms
- Pancreatic Neoplasms
Name | Location |
|---|---|
| Memorial Sloan Kettering Cancer Center | New York, New York 10021 |
